Delivery Order SPE2DB22D2009-SPE2DB25FL9SL
Award Date
6/13/25
Potential Completion Date
6/16/25
Potential Value
$8.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,513.78, is for the supply of Vraylar 1.5 mg capsules. The contract has a completion date of June 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,452.90, is for the delivery of Vraylar 3 mg capsules over the period ending on May 2, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,142,669 units of Vraylar 3 mg capsules. The total ceiling value of the contract is $5,905.92 and the ultimate completion date is May 6, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Vraylar 1.5 mg capsules to support military treatment programs and facilities. The contract has a ceiling value of $15,999.35 and a performance period through March 14, 2024. Amerisourcebergen Drug Corp also holds an Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,637.62, is for the supply of Vraylar 3 mg capsules to support federal healthcare programs. The award has an ultimate completion date of May 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vraylar 1.5 mg capsules, with a firm fixed price of $24,847.32 and a period of performance through May 16, 2025. The contract is not set aside and was awarded on May 15, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,941.41, is for the supply of Vraylar 3 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of medical commodities to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,221.25, is for the delivery of Vraylar 3 mg capsules. It is a firm fixed-price contract with an ultimate completion date of April 16, 2025. The contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Vraylar 3 mg capsules. The firm-fixed-price contract has a ceiling value of $7,614.22 and a period of performance through November 27, 2024. This order is placed against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables the...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Vraylar 3 mg capsules. The contract is a firm fixed-price delivery order with a ceiling value of $34,233.83 and a period of performance through May 21, 2025. The award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...